Herein, we developed a tumor-targeting gene delivery system based upon FRα-targeted lipoplexes and that includes a vector with a tumor-specific promoter (hTERT) to encode a gene (pMP) for ovarian cancer treatment. Here, FOLR1 is linked to ovarian carcinoma.